cyclobenzaprine and Colitis

cyclobenzaprine has been researched along with Colitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abedi, V; Bassaganya-Riera, J; Carbo, A; Girardin, S; Godfrey, V; Heltzel, C; Hontecillas, R; Kale, S; Langowski, M; Leber, A; Lu, P; Philipson, C; Tubau-Juni, N; Uren, A1
Boussetta, T; Driss, F; El-Benna, J; Gougerot-Pocidalo, MA; Lettéron, P; Marie, JC; Raad, H1

Other Studies

2 other study(ies) available for cyclobenzaprine and Colitis

ArticleYear
Modeling-Enabled Characterization of Novel NLRX1 Ligands.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Colitis; Drug Evaluation, Preclinical; Fatty Acids; Gene Expression Regulation; Humans; Ligands; Linolenic Acids; Mice; Mitochondrial Proteins; Molecular Docking Simulation; Mutation; NF-kappa B; Peptide Fragments; Protein Structure, Tertiary

2015
Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats.
    PloS one, 2009, Jul-31, Volume: 4, Issue:7

    Topics: Animals; Colitis; Linolenic Acids; Lymphocyte Activation; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Reactive Oxygen Species; Tumor Necrosis Factor-alpha

2009